Found: 9
Select item for more details and to access through your institution.
An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 5, p. 1461, doi. 10.1210/clinem/dgab905
- By:
- Publication type:
- Article
The public economic burden of suboptimal type 2 diabetes control upon taxpayers in Sweden: Looking beyond health costs.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1038, doi. 10.1111/dom.14667
- By:
- Publication type:
- Article
Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 2, p. 187, doi. 10.1007/s10198-022-01470-w
- By:
- Publication type:
- Article
The out‐of‐pocket cost of living with obesity: Results from a survey in Spain, South Korea, Brazil, India, Italy, and Japan.
- Published in:
- Obesity Science & Practice, 2024, v. 10, n. 4, p. 1, doi. 10.1002/osp4.70000
- By:
- Publication type:
- Article
Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 537, doi. 10.1007/s13300-020-00989-6
- By:
- Publication type:
- Article
The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1037, doi. 10.1007/s13300-018-0418-0
- By:
- Publication type:
- Article
The Economic Burden of Insulin-Related Hypoglycemia in Spain.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 4, p. 899, doi. 10.1007/s13300-017-0285-0
- By:
- Publication type:
- Article
Effect of once‐weekly subcutaneous semaglutide 2.4 mg on weight‐ and health‐related quality of life in an East Asian population: Patient‐reported outcomes from the STEP 6 trial.
- Published in:
- Clinical Obesity, 2023, v. 13, n. 4, p. 1, doi. 10.1111/cob.12589
- By:
- Publication type:
- Article
Impact of BMI and comorbidities on efficacy of once‐weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial.
- Published in:
- Obesity (19307381), 2023, v. 31, n. 4, p. 990, doi. 10.1002/oby.23732
- By:
- Publication type:
- Article